These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4649280)

  • 1. The influence of acenocumarole on the fibrinogen-turnover in normal subjects, venous thrombosis and congestive heart failure.
    van der Maas AP; Teulings FA; Schopman W; den Ottolander GJ
    Thromb Diath Haemorrh; 1972 Dec; 28(3):496-508. PubMed ID: 4649280
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of the fibrinogen turnover and the isotope scanning of the legs for the diagnosis of venous thrombosis in non surgical patients.
    Ottolander GJ; van der Maas AP; Schopmen W
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):277-83. PubMed ID: 4450186
    [No Abstract]   [Full Text] [Related]  

  • 3. Venous thrombosis.
    Gaylis H
    S Afr J Surg; 1970; 8(3):31-6. PubMed ID: 4925935
    [No Abstract]   [Full Text] [Related]  

  • 4. Leg vein thrombosis diagnosed by 125I-fibrinogen test after acute myocardial infarction.
    Kotilainen M; Ristola P; Ikkala E; Pyörälä K
    Ann Clin Res; 1973 Dec; 5(6):365-8. PubMed ID: 4792200
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use of I-131-fibrinogen in the diagnosis of venous thrombosis and in the evaluation of the effect of anticoagulant treatment].
    van der Maas AP; Teulings FA; Schopman W; den Ottolander GJ
    Ned Tijdschr Geneeskd; 1973 Sep; 117(37):1388-96. PubMed ID: 4787074
    [No Abstract]   [Full Text] [Related]  

  • 6. [On influencing prothrombin time (Quick) in the presence of acenocoumarol through the parenteral administration of trihydroxyethylrutoside].
    Maibach E
    Praxis; 1967 Jul; 56(30):1039-41. PubMed ID: 5633042
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemorheological alterations and hypercoagulable state in deep vein thrombosis.
    Mira Y; Vayá A; Martínez M; Villa P; Santaolaria ML; Ferrando F; Aznar J
    Clin Hemorheol Microcirc; 1998 Dec; 19(4):265-70. PubMed ID: 9972663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?
    Barcellona D; Vannini ML; Fenu L; Balestrieri C; Marongiu F
    Thromb Haemost; 1998 Dec; 80(6):899-902. PubMed ID: 9869157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic study of factor X during oral anticoagulation with acenocoumarol: potential value for the initiation of treatment.
    Aiach M; Fiessinger JN; Capron L; Nussas C; Housset E; Leclerc M
    Thromb Haemost; 1982 Feb; 47(1):69-71. PubMed ID: 7071808
    [No Abstract]   [Full Text] [Related]  

  • 10. Acenocoumarol and 6-mercaptopurine: an important drug interaction.
    Fernández MA; Regadera A; Aznar J
    Haematologica; 1999 Jul; 84(7):664-5. PubMed ID: 10406922
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of acenocoumarol on hemorheological parameters.
    Vayá A; Martínez M; Fernández A; Ripoll F; Moscardó F; Mira Y; Aznar J
    Clin Hemorheol Microcirc; 2001; 24(2):111-5. PubMed ID: 11381186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms--the Leiden Thrombophilia Study (LETS).
    Koster T; Rosendaal FR; Reitsma PH; van der Velden PA; Briët E; Vandenbroucke JP
    Thromb Haemost; 1994 Jun; 71(6):719-22. PubMed ID: 7974338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of deep venous thrombosis in patients with an acute myocardial infarction treated with acenocoumarol or indobufen.
    Peters SH; Jonker JJ; de Boer AC; den Ottolander GJ
    Thromb Haemost; 1982 Oct; 48(2):222-5. PubMed ID: 7179201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacology studies with acenocoumarol.
    Hirtz J; Le Roux Y; Jaouen A; Richard J; Blatrix C; Thébault JJ; Schoeller JP
    Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):361-5. PubMed ID: 489204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abrupt versus gradual withdrawal of vitamin K antagonist treatment in patients with venous thromboembolic disease: assessment of hypercoagulability and clinical outcome.
    de Groot MR; Njo TL; van Marwijk Kooy M; Büller HR
    Clin Lab; 2000; 46(11-12):575-81. PubMed ID: 11109505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
    Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
    Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of overanticoagulation in patients with heart failure on coumarin anticoagulants.
    Visser LE; Bleumink GS; Trienekens PH; Vulto AG; Hofman A; Stricker BH
    Br J Haematol; 2004 Oct; 127(1):85-9. PubMed ID: 15384981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fibrinolytic system and postoperative thrombosis following operation of rectal carcinoma. A preliminary report.
    Aberg M; Isacson S; Nilsson IM
    Acta Chir Scand; 1974; 140(5):352-4. PubMed ID: 4854836
    [No Abstract]   [Full Text] [Related]  

  • 19. The relation of platelet adhesiveness to postoperative venous thrombosis of the legs. A clinical study.
    Becker J
    Acta Chir Scand; 1972; 138(8):781-6. PubMed ID: 4641150
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolism of 131 I-fibrinogen in normal humans and monkeys.
    Areekul S; Devakul K; Vivatanasesth P; Kanakakorn K; Kasemsuth R
    Southeast Asian J Trop Med Public Health; 1971 Sep; 2(3):393-8. PubMed ID: 5003369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.